• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

持续动静脉血液滤过治疗急性肾衰竭的两年临床经验。

Two years clinical experience with continuous arteriovenous hemofiltration in acute renal failure.

作者信息

Domoto D T

出版信息

Trans Am Soc Artif Intern Organs. 1985;31:581-5.

PMID:3837512
Abstract

Clotting of hemofilters is the most frequent single cause of filter failure. These filters frequently clot in spite of acceptable hemodynamic and anticoagulation parameters. Sixty percent of filters which eventually clotted never filtered above 200 ml/hr. In our experience maximum ultrafiltration rates of 500 ml/hr to over 1000 ml/hr are rarely achieved in routine clinical usage. Finally, a disproportionate number of filters accessed to the lower leg either clotted or were discontinued for subsequent dialysis. Thus, we conclude that lower leg accesses should be avoided if possible. Further, to prevent clotting, in addition to maintaining adequate anticoagulation and cardiac output, maximum ultrafiltration rates should be sought. To achieve maximum ultrafiltration rates, a good vascular access is primary. Also, a vacuum system may be needed and perhaps routinely used to obtain filtration rates near 500 ml/hr. These high filtration rates will also reduce the need for hemodialysis, the second most common reason for filter discontinuation.

摘要

血液滤过器凝血是滤器失效最常见的单一原因。尽管血液动力学和抗凝参数可接受,但这些滤器仍频繁凝血。最终发生凝血的滤器中,60% 的滤过率从未超过200毫升/小时。根据我们的经验,在常规临床使用中,很少能达到500毫升/小时至超过1000毫升/小时的最大超滤率。最后,相当一部分下肢血管通路的滤器要么发生凝血,要么因后续透析而停用。因此,我们得出结论,应尽可能避免使用下肢血管通路。此外,为防止凝血,除维持足够的抗凝和心输出量外,应寻求最大超滤率。为达到最大超滤率,良好的血管通路是首要的。此外,可能需要并或许常规使用真空系统来获得接近500毫升/小时的滤过率。这些高滤过率也将减少血液透析的需求,血液透析是滤器停用的第二常见原因。

相似文献

1
Two years clinical experience with continuous arteriovenous hemofiltration in acute renal failure.持续动静脉血液滤过治疗急性肾衰竭的两年临床经验。
Trans Am Soc Artif Intern Organs. 1985;31:581-5.
2
[Continuous arteriovenous hemofiltration in acute renal failure. Value of regulating the rate of ultrafiltration].
Nephrologie. 1985;6(5):239-44.
3
[Continuous hemodialysis with cuprophan membranes in critical patients].[铜仿膜连续血液透析在危重症患者中的应用]
Rev Med Chil. 1994 Apr;122(4):394-400.
4
A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.一种具有可变治疗效果且能出色控制酸碱状态的安全枸橼酸盐抗凝方案。
Crit Care Med. 2009 Jun;37(6):2018-24. doi: 10.1097/CCM.0b013e3181a00a92.
5
Continuous hemofiltration in patients with acute renal failure.急性肾衰竭患者的连续性血液滤过
Acta Med Croatica. 1995;49(4-5):211-3.
6
The use of continuous arteriovenous hemofiltration in intensive care medicine.持续动静脉血液滤过在重症医学中的应用。
Acta Anaesthesiol Belg. 1984 Mar;35(1):67-78.
7
Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.连续性肾脏替代治疗:对出血高风险的危重症患者进行抗凝治疗。
J Nephrol. 2003 Jul-Aug;16(4):566-71.
8
[Continuous arteriovenous hemofiltration for the treatment of acute kidney failure].连续性动静脉血液滤过治疗急性肾衰竭
Schweiz Med Wochenschr. 1985 Feb 16;115(7):242-7.
9
Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations.持续静脉-静脉血液滤过可改善伴有急性肾衰竭的感染性休克患者的血流动力学,而不改变血浆肿瘤坏死因子α和白细胞介素6的浓度。
J Nephrol. 2002 Mar-Apr;15(2):150-7.
10
Accelerated venovenous hemofiltration: early technical and clinical experience.加速静脉-静脉血液滤过:早期技术与临床经验
Am J Kidney Dis. 2008 May;51(5):804-10. doi: 10.1053/j.ajkd.2008.01.012. Epub 2008 Mar 25.